Table 3.
Discrimination | Calibration | Clinical usefulness | ||
---|---|---|---|---|
AUC | H–L | PPV (%) | NPV (%) | |
30-day mortality | ||||
NHFS | 0.80 (0.72–0.87) | p = 0.164 | 14.9 | 100.0 |
Holt et al. | 0.86 (0.78–0.94) | p = 0.293 | 17.2 | 99.1 |
HEMA | 0.74 (0.63–0.85) | p = 0.025 | 17.9 | 96.8 |
1-year mortality | ||||
NHFS | 0.76 (0.70–0.82) | p = 0.322 | 40.5 | 95.0 |
Holt et al. | 0.79 (0.73–0.84) | p = 0.709 | 40.9 | 95.4 |
HEMA | 0.73 (0.66–0.80) | p = 0.331 | 48.7 | 89.1 |
8-year mortality | ||||
NHFS | 0.90 (0.86–0.93) | p = 0.063 | 98.6 | 72.4 |
Holt et al. | 0.89 (0.85–0.93) | p = 0.413 | 94.5 | 74.7 |
HEMA | 0.79 (0.75–0.84) | p < 0.001 | 97.4 | 40.5 |
Values in parentheses are 95% confidence intervals. AUC, area under the curve. H–L, Hosmer–Lemeshow goodness-of-fit test. Bold typeface indicates statistically significant results (p < 0.05). PPV, positive predictive value is the probability of death for a patient in the high-risk group. NPV, negative predictive value is the probability of survival for a patient in the low-risk group. NHFS, Nottingham Hip Fracture Score. HEMA, Hip fracture Estimator of Mortality Amsterdam